Artificial Intelligence Assists in the Detection of Blood Vessels in Whole Slide Images: Practical Benefits for Oncological Pathology

Biomolecules. 2023 Aug 29;13(9):1327. doi: 10.3390/biom13091327.

Abstract

The analysis of the microvasculature and the assessment of angiogenesis have significant prognostic value in various diseases, including cancer. The search for invasion into the blood and lymphatic vessels and the assessment of angiogenesis are important aspects of oncological diagnosis. These features determine the prognosis and aggressiveness of the tumor. Traditional manual evaluation methods are time consuming and subject to inter-observer variability. Blood vessel detection is a perfect task for artificial intelligence, which is capable of rapid analyzing thousands of tissue structures in whole slide images. The development of computer vision solutions requires the segmentation of tissue regions, the extraction of features and the training of machine learning models. In this review, we focus on the methodologies employed by researchers to identify blood vessels and vascular invasion across a range of tumor localizations, including breast, lung, colon, brain, renal, pancreatic, gastric and oral cavity cancers. Contemporary models herald a new era of computational pathology in morphological diagnostics.

Keywords: artificial intelligence; blood vessel detection; cancer; deep learning; digital pathology.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Artificial Intelligence*
  • Humans
  • Machine Learning
  • Medical Oncology
  • Microvessels
  • Mouth Neoplasms*

Grants and funding

The morphological studies of cancer biology were supported by the Russian Science Foundation (Grant No. 22-15-00467). The digital pathology studies were funded by the Ministry of Science and Higher Education of the Russian Federation under the grant agreement No. 075-15-2021-596. The literature investigation and training of AI models were financed by the Ministry of Science and Higher Education of the Russian Federation within the framework of state support for the creation and development of World-Class Research Centers “Digital biodesign and personalized healthcare” No. 075-15-2022-306.